Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
58.40
+0.40 (0.69%)
At close: Mar 4, 2026
12.74% (1Y)
| Market Cap | 6.27B +28.9% |
| Revenue (ttm) | 9.52B +28.6% |
| Net Income | 537.75M +28.4% |
| EPS | 4.99 +27.6% |
| Shares Out | 107.42M |
| PE Ratio | 11.71 |
| Forward PE | n/a |
| Dividend | 1.40 (2.41%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 284,459 |
| Average Volume | 742,326 |
| Open | 58.00 |
| Previous Close | 58.00 |
| Day's Range | 57.30 - 59.10 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | -0.08 |
| RSI | 48.69 |
| Earnings Date | Jan 28, 2026 |